Cargando…

Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model

INTRODUCTION: While current breast cancer chemoprevention strategies using selective estrogen response modulators and aromatase inhibitors are quite successful, their effects are limited to hormonally responsive breast cancer. Hormonally nonresponsive breast cancer (including estrogen receptor-negat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woditschka, Stephan, Haag, Jill D, Mau, Bob, Lubet, Ronald A, Gould, Michael N
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374974/ https://www.ncbi.nlm.nih.gov/pubmed/18279516 http://dx.doi.org/10.1186/bcr1864

Ejemplares similares

Freund's vaccine adjuvant promotes Her2/Neu breast cancer
por: Cotroneo, Michelle S, et al.
Publicado: (2009)

The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions
por: Smits, Bart MG, et al.
Publicado: (2011)

Immunogenicity of rat-neu(+) mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment
por: Sow, Heng Sheng, et al.
Publicado: (2020)

Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices
por: Aqil, Farrukh, et al.
Publicado: (2017)

Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Elmets, Craig A., et al.
Publicado: (2010)

Chemopreventive Effects of Propolis in the MNU-Induced Rat Mammary Tumor Model
por: Gal, A. F., et al.
Publicado: (2020)

Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
por: Noguchi, M., et al.
Publicado: (1997)

Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors
por: Cao, Zhijun, et al.
Publicado: (2019)

Hormonal control of p53 and chemoprevention
por: Jerry, D Joseph, et al.
Publicado: (2002)

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
por: Zujewski, JoAnne, et al.
Publicado: (2001)

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents
por: Xiong, Donghai, et al.
Publicado: (2016)

Cancer chemoprevention and therapy by monoterpenes.
por: Gould, M N
Publicado: (1997)

Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
por: Fry, Elizabeth A., et al.
Publicado: (2013)

Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer
por: Thompson, Matthew D., et al.
Publicado: (2017)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Quantification of Epithelial Cell Differentiation in Mammary Glands and Carcinomas from DMBA- and MNU-Exposed Rats
por: Sharma, Deepak, et al.
Publicado: (2011)

Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase
por: Zambrano, Joelle N., et al.
Publicado: (2018)

HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014)

Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
por: Provinciali, Mauro, et al.
Publicado: (2017)

Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic Mice
por: Cameron, Heather L., et al.
Publicado: (2009)

Accelerated Mammary Tumor Onset in a HER2/Neu Mouse Model Exposed to DDT Metabolites Locally Delivered to the Mammary Gland
por: Johnson, Nakpangi A, et al.
Publicado: (2012)

Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Carcinogenesis by Soy Foods or Biochanin A
por: Gotoh, Takahiko, et al.
Publicado: (1998)

Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Cancer by Miso and Tamoxifen, Alone and in Combination
por: Gotoh, Takahiko, et al.
Publicado: (1998)

Adherence to hormone therapy in a chemoprevention randomised trial
por: Atkins, L, et al.
Publicado: (2008)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma
por: Zhou, Yu, et al.
Publicado: (2019)

Cancer chemoprevention through dietary flavonoids: what’s limiting?
por: Amawi, Haneen, et al.
Publicado: (2017)

Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism
por: Shilkaitis, Anne, et al.
Publicado: (2005)

Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
por: Unni, Emmanual, et al.
Publicado: (2004)

Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
por: Wang, Ting, et al.
Publicado: (2017)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

Physical Confirmation and Mapping of Overlapping Rat Mammary Carcinoma Susceptibility QTLs, Mcs2 and Mcs6
por: Sanders, Jennifer, et al.
Publicado: (2011)

Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model
Publicado: (1994)

The Non-coding Mammary Carcinoma Susceptibility Locus, Mcs5c, Regulates Pappa Expression via Age-Specific Chromatin Folding and Allele-Dependent DNA Methylation
por: Henning, Amanda N., et al.
Publicado: (2016)

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
por: Lubet, Ronald A., et al.
Publicado: (2018)

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
por: Lubet, Ronald A., et al.
Publicado: (2019)

Effects of High-Fructose Diet vs. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA Expression
por: Kumar, Amit, et al.
Publicado: (2021)

Erratum to: Cancer chemoprevention through dietary flavonoids: what’s limiting?
por: Amawi, Haneen, et al.
Publicado: (2017)

Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis
por: Bishayee, Anupam, et al.
Publicado: (2016)

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
por: Boggio, Katia, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_j1pag5hre60v72gddkpebe03ej